Lupin Limited recalls Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Recall notice
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Contact the company & request your remedy
We’re still writing up this recall
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
Source Page by GovInfoNow · govinfonow.com/recall/43137-lupin-limited-recalls-amlodipine-besylate-tablets-usp-2-5mg-90 · Recall date February 19, 2016 · FDA enforcement record: FDA #D-1492-2016
Cite this page
“Lupin Limited recalls Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc..” GovInfoNow, recall dated February 19, 2016. https://govinfonow.com/recall/43137-lupin-limited-recalls-amlodipine-besylate-tablets-usp-2-5mg-90. Based on FDA recall #D-1492-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1492-2016%22&limit=1).
How to tell if you have this one
- Brand
Lupin Limited- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
US No recalled product was distributed to any foreign consignees by Lupin.- NDC
68180-750-09, 68180-751-09, 68180-751-03, 68180-751-17, 68180-752-09, 68180-752-03, 68180-719-03, 68180-719-09, 68180-720-09, 68180-720-03, 68180-721-03, 68180-721-09, 68180-233-01, 68180-233-02, 68180-455-02, 68180-455-01
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1492-2016 | Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-750-09; Lot #: G304799, Exp. 4/2016 | 43,536 bottles |
| D-1493-2016 | Amlodipine Besylate Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-752-03; Lot #: G304677, G304540, G304536, G304537, G304535, G304541, G304545, G304533, G304532, G304539, G304538, G304534, Exp. 4/2016 | 11,812 bottles |
Contact Lupin Limited
We’ve drafted a message you can send Lupin Limited to request your refund or repair — edit it as you like.
Subject: Recall D-1492-2016 — Lupin Limited Lupin Limited recalls Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx on Hello, I own a Lupin Limited recalls Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. that is covered by recall D-1492-2016 from Lupin Limited. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1492-2016 (February 19, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1492-2016 to see it in context.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
